Cargando…

69399 How are substance use disorder treatment programs in Arkansas responding to COVID-19? A qualitative study

ABSTRACT IMPACT: This study informs how substance use treatment programs responded to the COVID-19 pandemic, and highlights implication for future translational research and practice. OBJECTIVES/GOALS: The COVID-19 pandemic rapidly changed how substance use disorder (SUD) treatment services are orga...

Descripción completa

Detalles Bibliográficos
Autores principales: Baloh, Jure, Curran, Geoffrey M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827721/
http://dx.doi.org/10.1017/cts.2021.550
_version_ 1784647695587082240
author Baloh, Jure
Curran, Geoffrey M.
author_facet Baloh, Jure
Curran, Geoffrey M.
author_sort Baloh, Jure
collection PubMed
description ABSTRACT IMPACT: This study informs how substance use treatment programs responded to the COVID-19 pandemic, and highlights implication for future translational research and practice. OBJECTIVES/GOALS: The COVID-19 pandemic rapidly changed how substance use disorder (SUD) treatment services are organized and provided. This study examined what changes SUD treatment programs in Arkansas implemented (e.g., guidelines, technologies), and what factors influenced their ability to implement and sustain these changes. METHODS/STUDY POPULATION: Between May and August 2020, we conducted semi-structured phone interviews with 29 leaders (administrative and/or clinical leaders) at 21 residential and outpatient SUD treatment programs throughout Arkansas (i.e., in all five Arkansas public health regions). Interviews were based on the Consolidated Framework for Implementation Research and focused on what changes programs were implementing in response to the COVID-19 pandemic, barriers and facilitators to implementation, and recommendations for future. The interviews were on average about 30 minutes long, and we provided no participant compensation. Interviews were recorded and transcribed verbatim, then thematically analyzed. RESULTS/ANTICIPATED RESULTS: Programs implemented similar infection control practices: screening at entry, masks, hand hygiene, and social distancing. Residential programs stopped outside visitations and some capped admissions; outpatient programs stopped group sessions and switched most services to telehealth. Key facilitators included grants/loans (e.g., salaries), looser regulatory restrictions (e.g., telehealth), and good coordination with other organizations (e.g., state agencies). Key barriers included limited access to supplies (e.g., masks), no rapid testing (particularly for residential care), limited capacity for social distancing, and negative employee and client responses (e.g., anxiety). Key recommendations include better access to supplies and testing, telehealth continuation and better communication. DISCUSSION/SIGNIFICANCE OF FINDINGS: This study provides an insight into how SUD programs responded to the COVID-19 pandemic and what the ‘new normal’ is. This can inform D&I studies conducted in SUD settings, including studies examining what implementation strategies can help sustain these changes, or studies of other practices implemented during or after the pandemic.
format Online
Article
Text
id pubmed-8827721
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-88277212022-02-28 69399 How are substance use disorder treatment programs in Arkansas responding to COVID-19? A qualitative study Baloh, Jure Curran, Geoffrey M. J Clin Transl Sci Dissemination and Implementation ABSTRACT IMPACT: This study informs how substance use treatment programs responded to the COVID-19 pandemic, and highlights implication for future translational research and practice. OBJECTIVES/GOALS: The COVID-19 pandemic rapidly changed how substance use disorder (SUD) treatment services are organized and provided. This study examined what changes SUD treatment programs in Arkansas implemented (e.g., guidelines, technologies), and what factors influenced their ability to implement and sustain these changes. METHODS/STUDY POPULATION: Between May and August 2020, we conducted semi-structured phone interviews with 29 leaders (administrative and/or clinical leaders) at 21 residential and outpatient SUD treatment programs throughout Arkansas (i.e., in all five Arkansas public health regions). Interviews were based on the Consolidated Framework for Implementation Research and focused on what changes programs were implementing in response to the COVID-19 pandemic, barriers and facilitators to implementation, and recommendations for future. The interviews were on average about 30 minutes long, and we provided no participant compensation. Interviews were recorded and transcribed verbatim, then thematically analyzed. RESULTS/ANTICIPATED RESULTS: Programs implemented similar infection control practices: screening at entry, masks, hand hygiene, and social distancing. Residential programs stopped outside visitations and some capped admissions; outpatient programs stopped group sessions and switched most services to telehealth. Key facilitators included grants/loans (e.g., salaries), looser regulatory restrictions (e.g., telehealth), and good coordination with other organizations (e.g., state agencies). Key barriers included limited access to supplies (e.g., masks), no rapid testing (particularly for residential care), limited capacity for social distancing, and negative employee and client responses (e.g., anxiety). Key recommendations include better access to supplies and testing, telehealth continuation and better communication. DISCUSSION/SIGNIFICANCE OF FINDINGS: This study provides an insight into how SUD programs responded to the COVID-19 pandemic and what the ‘new normal’ is. This can inform D&I studies conducted in SUD settings, including studies examining what implementation strategies can help sustain these changes, or studies of other practices implemented during or after the pandemic. Cambridge University Press 2021-03-30 /pmc/articles/PMC8827721/ http://dx.doi.org/10.1017/cts.2021.550 Text en © The Association for Clinical and Translational Science 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Dissemination and Implementation
Baloh, Jure
Curran, Geoffrey M.
69399 How are substance use disorder treatment programs in Arkansas responding to COVID-19? A qualitative study
title 69399 How are substance use disorder treatment programs in Arkansas responding to COVID-19? A qualitative study
title_full 69399 How are substance use disorder treatment programs in Arkansas responding to COVID-19? A qualitative study
title_fullStr 69399 How are substance use disorder treatment programs in Arkansas responding to COVID-19? A qualitative study
title_full_unstemmed 69399 How are substance use disorder treatment programs in Arkansas responding to COVID-19? A qualitative study
title_short 69399 How are substance use disorder treatment programs in Arkansas responding to COVID-19? A qualitative study
title_sort 69399 how are substance use disorder treatment programs in arkansas responding to covid-19? a qualitative study
topic Dissemination and Implementation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827721/
http://dx.doi.org/10.1017/cts.2021.550
work_keys_str_mv AT balohjure 69399howaresubstanceusedisordertreatmentprogramsinarkansasrespondingtocovid19aqualitativestudy
AT currangeoffreym 69399howaresubstanceusedisordertreatmentprogramsinarkansasrespondingtocovid19aqualitativestudy